| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-884
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-812
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-86 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-7051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 |
| filingDate |
2021-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87730f9aebca5b1e17c382558c7c4470
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ce6bb05dedabbd40c677e0d58bd0f3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a4883bd24f7c3e776e5158cf8ce12d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19acc7c1e67094137a6b2622b6320775 |
| publicationDate |
2021-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021163562-A2 |
| titleOfInvention |
Compositions and methods comprising splicing-derived antigens for treating cancer |
| abstract |
Methods and processes to identify neoplastic tissue antigens derived from alternative splicing (AS) are described, in accordance with various embodiments of the invention. Also described are novel tumor antigens that are useful as targets in various immunotherapeutic approaches to treating cancer as well as novel engineered T cell Receptors (TCRs) and chimeric antigen receptors (CARs) that target these antigenic peptides. |
| priorityDate |
2020-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |